動物用感染症診断市場レポート：技術別、動物タイプ別、感染タイプ別、エンドユーザー別、地域別、2024～2032年

世界の動物用感染症診断市場規模は2023年に20億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに40億米ドルに達し、2024～2032年の間に7.4％の成長率（CAGR）を示すと予測しています。ペットや家畜における疾病の蔓延、飼い主の意識の高まり、技術の進歩、正確な診断の必要性、先進ツールの採用、ペットの健康に対する関心の高まり、獣医療的インフラの拡大、人獣共通感染症予防のための政府の取り組み、研究資金の強化などが市場成長を促進する要因となっています。

動物用感染症診断市場分析：

主要市場促進要因世界的に、人獣共通感染症の流行が増加しているため、高度な診断ソリューションに対する需要が大幅に増加しており、市場の明るい展望が生まれています。さらに、動物医療に対する政府の取り組みや資金提供の増加が、動物用感染症診断市場の成長を促進しています。さらに、畜産業の拡大や大手企業による研究開発（R&D）活動への取り組みが活発化していることも、市場の成長を後押ししています。さらに、ポイントオブケア（POC）診断の利用拡大、獣医療における遠隔医療の利用急増、動物福祉と品質基準に関する消費者の意識の高まりが、獣医感染症診断の需要をさらに押し上げています。

主要市場動向：優れた感度と特異性による分子診断への嗜好の変化は、主要な市場動向の一つです。さらに、CRISPR（clustered regularly interspaced short palindromic repeats）はオンサイトで操作できるため、診断への利用が急増していることも市場成長を促進する要因となっています。さらに、人工知能（AI）と機械学習（ML）の統合が進み、特に診断ツールにおいて、より正確な結果が得られるようになったことが、動物用感染症診断市場の前向きな展望を後押ししています。これに伴い、コンパニオンアニマルに対する需要の増加と、様々な病原体を同時に検出するマルチプレックス診断アッセイへの漸進的なシフトが市場の成長を促進しています。さらに、動物病院と診断ラボの連携や、ポイントオブケア（POC）診断ソリューションに対する需要の急増が市場を牽引しています。

地理的動向：動物用感染症診断市場予測によると、北米は高度な医療インフラの存在、ペット飼育頭数の増加、動物の健康に対する投資の急増により市場をリードしています。さらに、主要企業による研究開発（R&D）への注力の高まりと政府の好意的な政策が、この地域の市場成長を支えています。欧州は、厳しい動物衛生規制と多数の主要市場参入企業の存在により、市場でかなりのシェアを占めています。さらに、アジア太平洋では、動物衛生に対する意識の高まり、感染性診断の容易な入手可能性、動物衛生における政府資金の急増が市場成長を加速させています。

競合情勢：動物用感染症診断業界の主要市場参入企業には、Abbott Laboratories、Biomerieux SA、Creative Diagnostics、HESKA Corporation、Innovative Diagnostics、IDEXX Laboratories Inc.、Neogen Corporation、Qiagen N.V.、Randox Laboratories Ltd、Thermo Fisher Scientific Inc.、Virbacなどがあります。

課題と機会：動物用感染症診断市場レポートによると、診断ツールのコスト高騰は市場成長を阻害する主要要因の一つです。さらに、規制上の障害や複雑な承認プロセスが市場参入者に様々な課題をもたらしており、これも市場成長を抑制する要因となっています。しかし、動物における感染症の流行やペットの飼育数の増加により、高度な診断に対する大きな需要が確立されるなど、市場にはさまざまな機会ももたらされています。さらに、便利で使いやすい診断機器の登場を含む技術の急速な発展や、獣医の健康と福祉に対する関心の高まりは、動物用感染症診断市場の収益を大幅に押し上げる要因となっています。

動物用感染症診断市場の動向：

ペットと家畜における感染症の流行拡大

ペットや家畜の間で感染症の流行が増加していることが市場の成長を加速させています。例えば、猫白血病ウイルス（FeLV）は猫で最も一般的な感染症の一つであり、米国とカナダでは猫の2～3％が罹患しています。このリスクは、ペットと人間の間の相互作用の急増によってさらに増幅され、病気感染の可能性をさらにエスカレートさせています。さらに、急速な都市化、動物の飼育方法の変化、診断患者数の増加が市場の成長を支えています。動物用感染症診断市場の値を押し上げるもう1つの要因は、これらの疾病の効率的な制御と封じ込めを支援できる正確でタイムリーな診断に対する需要が急増していることです。

ペットオーナーの意識の高まり

疾病の早期発見の重要性に対する飼い主の意識の高まりは、市場の成長を促進する重要な要因です。ペットは不可欠な家族の一員であると考えられているため、飼い主はますますペットの健康と幸福を優先するようになっています。このような意識の高まりにより、定期的な健康診断、予防措置、早期診断試験に対する需要が高まっています。さらに、高度な診断ツールや技術が利用できるようになったことで、ペットの飼い主が質の高い獣医療を受けやすくなり、感染症診断の需要をさらに押し上げています。

技術の進歩

市場概要によると、動物用感染症診断は、急速な技術進歩によりかなりの需要が見られます。診断の改善により、診断結果の効率と精度が大幅に向上し、市場の成長をさらに後押ししています。さらに、ポリメラーゼ連鎖反応（PCR）のような、動物感染症の検出と同定を改善するために設計された分子診断技術の導入が、市場の成長を促進しています。これとは別に、自動分析装置や遠隔医療プラットフォームなどのデジタルヘルスツールの導入が診断プロセスを簡素化しており、これが市場の成長をさらに後押ししています。

動物用感染症診断市場セグメンテーション：

IMARC Groupは、市場の各セグメントにおける主要動向の分析と、2024～2032年までの世界、地域、国レベルの予測を提供しています。当レポートでは、市場を技術、動物タイプ、感染タイプ、エンドユーザーに基づいて分類しています。

技術別内訳

免疫診断が市場シェアの大半を占める

本レポートでは、技術別に市場を詳細に区分・分析しています。これには免疫診断、分子診断、その他が含まれます。同レポートによると、免疫診断が最大のセグメントを占めています。

調査レポート「市場セグメンテーション」によると、正確な疾患検出に対する需要の増加により、免疫診断学セグメントが最大の市場シェアを占めています。酵素結合免疫吸着測定法（ELISA）や免疫蛍光測定法（IFA）を含む免疫診断試験は、感染症に関連する抗体や抗原を特異的に検出する能力が不可欠です。この精度は、病原体を特定し、効果的な治療と疾病管理に不可欠な疾病を早期に診断する上で極めて重要です。獣医療が高度化するにつれ、決定的な結果を迅速に提供できる信頼性の高い診断ツールへの期待が高まっています。ペットや家畜における感染症の蔓延が深刻化していることから、このような正確な診断ソリューションの必要性が高まっています。

動物タイプ別内訳

コンパニオンアニマルが業界最大シェア

動物タイプ別の市場の詳細な区分と分析もレポートで提供されています。これにはコンパニオンアニマルと食品生産動物が含まれます。報告書によると、コンパニオンアニマルが最大の市場シェアを占めています。

動物用感染症診断市場のコンパニオンアニマルセグメントは、ペットの健康とウェルネスへの注目、診断技術の進歩によって牽引されています。さらに、ペットの飼い主が病気の早期発見を優先するようになり、積極的な健康管理のメリットを認識するようになったことも市場成長を後押ししています。このような意識の高まりにより、重篤化する前に病気を特定できる診断サービスへの需要が高まり、ペットの健康状態の改善につながります。このセグメントは、分子アッセイや迅速なポイントオブケア試験など、正確でタイムリーな結果を提供する高度な診断ツールが利用可能になったことも牽引しています。これらの技術革新により、獣医師は感染症をより効果的に診断・治療できるようになり、コンパニオンアニマルのケア全体の質が向上します。

感染症タイプ別内訳：

細菌感染症が市場の主要セグメントを占める

本レポートでは、感染タイプ別の市場の詳細な区分と分析を行っています。これには細菌感染、ウイルス感染、寄生虫感染、その他が含まれます。それによると、細菌感染症が最大のセグメントを占めています。

動物用感染症診断市場の細菌感染症セグメントは、効果的な管理と制御のための高度な診断ツールを必要とする動物の間で細菌性疾患の急増有病率によって駆動されます。ペットと家畜の両方でレプトスピラ症、結核、サルモネラ菌などの細菌感染症の発生率が上昇していることが、精密な診断ソリューションの需要を煽っています。また、細菌性疾患が動物の健康と生産性に与える影響に対する意識の高まりも、早期発見と介入を確実にするための強固な診断手法の必要性を高めています。さらに、家畜の細菌感染が食糧供給の汚染につながる可能性があり、厳格な試験とモニタリングの要件が求められていることから、このセグメントは食品の安全性に焦点が移っていることが背景にあります。特に新興国では、獣医医療インフラとサービスの拡大が、診断技術へのアクセスを強化することでこのセグメントの成長を支えています。

エンドユーザー別内訳

基準試験室が市場を独占

本レポートでは、市場をエンドユーザー別に詳細に区分・分析しています。これには、基準試験室、動物用試験室とクリニック、POC/院内試験、研究機関と大学が含まれます。同レポートによると、基準試験室が最大のセグメントを占めています。

動物用感染症診断市場の基準試験室セグメントは、診断試験要件の複雑化によって牽引されています。獣医療的診断が高度化するにつれて、レファレンスラボラトリーはその高度な能力と専門的な専門知識でますます頼りにされるようになっています。このセグメントは、様々な病原体や疾病を区別できる正確で包括的な診断試験へのニーズの高まりによって牽引されています。このような複雑さゆえに、高度に専門化された機器と熟練した人材の使用が必要とされるが、これらは標準試験室の特徴です。その他の特典としては、徹底的で高解像度の分析を必要とする診断用サンプルの量が増加していることが挙げられます。分子診断やゲノム解析のような高度な試験法に対する需要の高まりは、これらの試験を高精度で実施できる専門的な標準試験機関に対するニーズを高めています。

地域別内訳

北米が市場をリードし、最大の動物用感染症診断市場シェアを占める

本レポートでは、北米（米国、カナダ）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、ラテンアメリカ（ブラジル、メキシコ、その他）、中東アフリカを含む主要地域市場についても包括的に分析しています。同レポートによると、北米は動物用感染症診断の最大地域市場です。

北米の動物用感染症診断市場は、ペットや家畜の間で感染症が蔓延していることです。同地域では、犬ジステンパー、猫白血病、各種人獣共通感染症などの罹患率が上昇しており、効果的な診断ソリューションの必要性が高まっています。この地域の市場は、病気の早期発見と予防の重要性に対する飼い主の意識の高まりによっても牽引されています。北米のペットオーナーはペットの健康についてより多くの情報を得て積極的に行動しており、これが高度な診断サービスへの需要を促進しています。さらに、分子生物学、迅速試験法、自動分析装置の技術革新など、獣医療的診断における技術進歩の急増が市場の成長を支えています。これらの進歩により、診断プロセスの精度、スピード、効率が向上しています。これとは別に、官民双方からの多額の投資に支えられた獣医療研究開発（R&D）への注目の高まりが市場を牽引しています。

競合情勢：

市場調査レポートでは、市場の競合情勢についても包括的に分析しています。すべての主要企業の詳細プロファイルも提供しています。動物用感染症診断業界の主要な市場参入企業には、Abbott Laboratories、Biomerieux SA、Creative Diagnostics、HESKA Corporation、Innovative Diagnostics、IDEXX Laboratories Inc.、Neogen Corporation、Qiagen N.V.、Randox Laboratories Ltd、Thermo Fisher Scientific Inc.、Virbac.などがあります。

（これは主要参入企業の一部一覧であり、完全なリストは報告書に記載されていることに留意されたい）。

市場の主要な動物用感染症診断企業の中には、競合を維持し市場成長を促進するため、いくつかの戦略的イニシアティブに積極的に取り組んでいる企業もあります。これらの企業は、診断技術の革新と強化のために広範な研究開発に注力しています。研究開発に多額の投資を行うことで、分子アッセイや迅速試験装置など、感染症の検出においてより高い精度とスピードを提供する先進的な診断ツールの導入を目指しています。研究機関や学術団体との連携も優先事項であり、最先端の技術やソリューションの開発を促進しています。さらに、これらの企業は戦略的買収や提携を通じて製品ポートフォリオを拡大し、より広範な診断ソリューションの提供や新市場への参入を可能にしています。また、高品質の診断製品に対する需要の高まりに対応するため、製造能力の強化も進めています。主要企業はまた、診断プロセスを改善し、リアルタイムの結果と予測的洞察を提供する統合ソリューションを提供するために、デジタル技術とデータ解析を採用しています。

動物用感染症診断市場ニュース：

2023年、IDEXX Laboratoriesは犬猫の腎障害を検出する先駆的な動物用診断試験を発表しました。この種の試験としては初めてとなるこの試験は、動物医療におけるアンメットニーズに対応する高度な診断ソリューションでポートフォリオを拡大するIDEXXの戦略の一環です。この新しい試験により、ペットの早期診断と治療成績が大幅に改善され、QOLが向上し、寿命が延びることが期待されます。

2023年、MarsはHESKA Corporationを買収し、HESKAをマースペットケアの研究開発部門に統合することで、高度な診断技術へのアクセスを大幅に拡大し、研究開発イニシアチブを加速させる。この買収により、HESKAはPOC（ポイントオブケア）診断、遠隔医療、革新的な技術を含む総合的な診断ソリューションを世界中の獣医専門家に提供する能力を強化することが期待されます。

2024年、Neogen CorporationはSureKill Gel Bait Pro Applicatorの採用より製品ラインを拡大しました。SureKill製品ラインへのこの新しい追加は、特に動物の健康が優先される環境における害虫駆除ソリューションを強化することを目的としています。このアプリケーターは効率的で効果的な害虫駆除を提供し、家畜やペットにより安全で健康的な環境を保証するよう設計されています。

本レポートで扱う主要質問

• 世界の動物用感染症診断市場はこれまでどのように推移してきたか？
• 動物用感染症診断市場の世界市場における促進要因、抑制要因、機会は何か？
• 各駆動要因、抑制要因、機会が世界の動物用感染症診断市場に与える影響は？
• 主要地域市場とは？
• 最も魅力的な動物用感染症診断市場はどの国か？
• 技術別の市場内訳は？
• 動物用感染症診断市場で最も魅力的な技術は？
• 動物タイプによる市場内訳は？
• 動物用感染症診断市場で最も魅力的な動物種は？
• 感染タイプ別の市場内訳は？
• 動物用感染症診断市場で最も魅力的な感染症タイプは？
• エンドユーザー別の市場内訳は？
• 動物用感染症診断市場で最も魅力的なエンドユーザーは？
• 市場の競合構造は？
• 世界の動物用感染症診断市場における主要参入企業/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の動物用感染症診断市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：技術別

• 免疫診断
• 分子診断
• その他

第7章 市場内訳：動物タイプ別

• コンパニオンアニマル
• 食用動物

第8章 市場内訳：感染タイプ別

• 細菌感染症
• ウイルス感染
• 寄生虫感染症
• その他

第9章 市場内訳：エンドユーザー別

• リファレンスラボ
• 獣医療研究所とクリニック
• ポイントオブケア/社内試験
• 研究機関と大学

第10章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第11章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第14章 価格分析

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • Biomerieux SA
  • Creative Diagnostics
  • HESKA Corporation
  • Innovative Diagnostics
  • IDEXX Laboratories Inc.
  • Neogen Corporation
  • Qiagen N.V.
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc
  • Virbac

List of Figures

• Figure 1: Global: Veterinary Infectious Disease Diagnostics Market: Major Drivers and Challenges
• Figure 2: Global: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Veterinary Infectious Disease Diagnostics Market: Breakup by Technology (in %), 2023
• Figure 5: Global: Veterinary Infectious Disease Diagnostics Market: Breakup by Animal Type (in %), 2023
• Figure 6: Global: Veterinary Infectious Disease Diagnostics Market: Breakup by Infection Type (in %), 2023
• Figure 7: Global: Veterinary Infectious Disease Diagnostics Market: Breakup by End User (in %), 2023
• Figure 8: Global: Veterinary Infectious Disease Diagnostics Market: Breakup by Region (in %), 2023
• Figure 9: Global: Veterinary Infectious Disease Diagnostics (Immunodiagnostics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 10: Global: Veterinary Infectious Disease Diagnostics (Immunodiagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 11: Global: Veterinary Infectious Disease Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 12: Global: Veterinary Infectious Disease Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 13: Global: Veterinary Infectious Disease Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 14: Global: Veterinary Infectious Disease Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 15: Global: Veterinary Infectious Disease Diagnostics (Companion Animals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 16: Global: Veterinary Infectious Disease Diagnostics (Companion Animals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 17: Global: Veterinary Infectious Disease Diagnostics (Food Producing Animals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 18: Global: Veterinary Infectious Disease Diagnostics (Food Producing Animals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 19: Global: Veterinary Infectious Disease Diagnostics (Bacterial Infections) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 20: Global: Veterinary Infectious Disease Diagnostics (Bacterial Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 21: Global: Veterinary Infectious Disease Diagnostics (Viral Infections) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 22: Global: Veterinary Infectious Disease Diagnostics (Viral Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 23: Global: Veterinary Infectious Disease Diagnostics (Parasitic Infections) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 24: Global: Veterinary Infectious Disease Diagnostics (Parasitic Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 25: Global: Veterinary Infectious Disease Diagnostics (Other Infection Types) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 26: Global: Veterinary Infectious Disease Diagnostics (Other Infection Types) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 27: Global: Veterinary Infectious Disease Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 28: Global: Veterinary Infectious Disease Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 29: Global: Veterinary Infectious Disease Diagnostics (Veterinary Laboratories and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 30: Global: Veterinary Infectious Disease Diagnostics (Veterinary Laboratories and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 31: Global: Veterinary Infectious Disease Diagnostics (Point of Care/In House Testing) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 32: Global: Veterinary Infectious Disease Diagnostics (Point of Care/In House Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 33: Global: Veterinary Infectious Disease Diagnostics (Research Institutes and Universities) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 34: Global: Veterinary Infectious Disease Diagnostics (Research Institutes and Universities) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 35: North America: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 36: North America: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 37: United States: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 38: United States: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 39: Canada: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 40: Canada: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 41: Asia-Pacific: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 42: Asia-Pacific: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 43: China: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 44: China: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 45: Japan: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 46: Japan: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 47: India: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 48: India: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 49: South Korea: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 50: South Korea: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 51: Australia: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 52: Australia: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 53: Indonesia: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 54: Indonesia: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 55: Others: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 56: Others: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 57: Europe: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 58: Europe: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 59: Germany: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 60: Germany: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 61: France: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 62: France: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 63: United Kingdom: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 64: United Kingdom: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 65: Italy: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 66: Italy: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 67: Spain: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 68: Spain: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 69: Russia: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 70: Russia: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 71: Others: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 72: Others: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 73: Latin America: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 74: Latin America: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 75: Brazil: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 76: Brazil: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 77: Mexico: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 78: Mexico: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 79: Others: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 80: Others: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 81: Middle East and Africa: Veterinary Infectious Disease Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
• Figure 82: Middle East and Africa: Veterinary Infectious Disease Diagnostics Market: Breakup by Country (in %), 2023
• Figure 83: Middle East and Africa: Veterinary Infectious Disease Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 84: Global: Veterinary Infectious Disease Diagnostics Industry: SWOT Analysis
• Figure 85: Global: Veterinary Infectious Disease Diagnostics Industry: Value Chain Analysis
• Figure 86: Global: Veterinary Infectious Disease Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Veterinary Infectious Disease Diagnostics Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Veterinary Infectious Disease Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
• Table 3: Global: Veterinary Infectious Disease Diagnostics Market Forecast: Breakup by Animal Type (in Million US$), 2024-2032
• Table 4: Global: Veterinary Infectious Disease Diagnostics Market Forecast: Breakup by Infection Type (in Million US$), 2024-2032
• Table 5: Global: Veterinary Infectious Disease Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
• Table 6: Global: Veterinary Infectious Disease Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 7: Global: Veterinary Infectious Disease Diagnostics Market: Competitive Structure
• Table 8: Global: Veterinary Infectious Disease Diagnostics Market: Key Players

The global veterinary infectious disease diagnostics market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. Increasing disease prevalence in pets and livestock, rising pet owner awareness, surging technological advancements, the need for accurate diagnostics, adoption of advanced tools, heightened pet health concerns, expanding veterinary infrastructure, government initiatives for zoonotic disease prevention, and enhanced research funding are factors fueling the market growth.

Veterinary Infectious Disease Diagnostics Market Analysis:

Major Market Drivers: Globally, the rising prevalence of zoonotic diseases is significantly increasing the demand for advanced diagnostic solutions, creating a positive outlook for the market. Additionally, increasing government initiatives and funding for animal healthcare is driving the veterinary infectious disease diagnostics market growth. Moreover, the expansion of livestock industry and escalating initiatives by major players for conducting research and development (R&D) activity is propelling the market growth. Additionally, increasing utilization of point-of-care (POC) diagnostics, burgeoning telemedicine usage for veterinary care, and growing consumer awareness about animal welfare and quality standards are further boosting the veterinary infectious disease diagnostics demand.

Key Market Trends: The shifting preference toward molecular diagnostics due to their superior sensitivity and specificity is one of the primary market trends. Moreover, the surging use of clustered regularly interspaced short palindromic repeats (CRISPR) for diagnostics as it can be operated on-site is another factor facilitating the market growth. Additionally, the rising integration of artificial intelligence (AI) and machine learning (ML), especially in diagnostic tools, to produce more accurate results is fostering a positive veterinary infectious disease diagnostics market outlook. In line with this, the increasing demand for companion animals and the gradual shift towards multiplex diagnostic assays that detect a variety of pathogens at the same time are fueling the market growth. Furthermore, the collaborations between veterinary practices and diagnostic laboratories and burgeoning demand for point-of-care (POC) diagnostic solutions are driving the market forward.

Geographical Trends: As per the veterinary infectious disease diagnostics market forecast, North America leads the market due to the presence of advance healthcare infrastructure, along with growing number pet ownership and burgeoning investment in animal health. Moreover, the increasing focus on research and development (R&D) by key players and favorable government policies are supporting the regional market growth. Europe holds a considerable share in the market due to stringent animal health regulations and the presence of a number of key market players. Furthermore, in Asia Pacific, the growing awareness of animal health, the easy availability of infectious diagnostics, and burgeoning government funding in animal health are accelerating the market growth.

Competitive Landscape: Some of the major market players in the veterinary infectious disease diagnostics industry include Abbott Laboratories, Biomerieux SA, Creative Diagnostics, HESKA Corporation, Innovative Diagnostics, IDEXX Laboratories Inc., Neogen Corporation, Qiagen N.V., Randox Laboratories Ltd, Thermo Fisher Scientific Inc, and Virbac, among many others.

Challenges and Opportunities: As per the veterinary infectious disease diagnostics market report, the burgeoning cost of diagnostic tools is one of the primary factors hindering the market growth. Additionally, regulatory obstacles and complex approval processes are creating various challenges for the market players, which is another factor restraining the market growth. However, the market also offers various opportunities, such as the increasing prevalence of infectious diseases in animals and rising pet ownership are establishing a huge demand for advanced diagnostics. Moreover, rapid developments in technology, including the emergence of convenient and easy-to-use diagnostic devices and the growing concern about veterinary health and welfare are factors providing a considerable boost to the veterinary infectious disease diagnostics market revenue.

Veterinary Infectious Disease Diagnostics Market Trends:

Growing Prevalence of Infectious Diseases in Pets and Livestock

Increasing prevalence of infectious diseases among pets and livestock is accelerating the market growth. For instance, feline leukemia virus (FeLV) is one of the most common infectious diseases in cats, affecting between 2-3% of felines in the US and Canada. The risk is further amplified by the surging interactions among pets and humans, which is further escalating the chances of disease transmission. Moreover, the rapid urbanization, changes in animal husbandry practices, and the rising number of diagnosed patients are supporting the market growth. Another factor boosting the veterinary infectious disease diagnostics market value is the burgeoning demand for accurate and timely diagnostics that can assist with efficient control and containment of these diseases.

Increasing Awareness Among Pet Owners

Rising awareness among pet owners about the importance of early disease detection is a crucial factor driving the market growth. With pets being considered integral family members, owners are increasingly prioritizing their health and well-being. This heightened awareness has led to a growing demand for regular health check-ups, preventive measures, and early diagnostic tests. Additionally, the availability of advanced diagnostic tools and technologies has made it easier for pet owners to access high-quality veterinary care, further driving the demand for infectious disease diagnostics.

Technological Advancements

According to the market overview, veterinary infectious disease diagnostics are witnessing considerably demand due to rapid technological advancements. Improvements in diagnostic have greatly improved the efficiency and accuracy of the results, which is further fueling the market growth. Furthermore, the introduction of molecular diagnostic technologies, such as polymerase chain reaction (PCR), designed to improve detection and identification in animal infectious diseases is facilitating the market growth. Apart from this, the incorporation of digital health tools, such as automated analyzers and telemedicine platforms, have simplified the diagnostics process, which is further supporting the market growth.

Veterinary Infectious Disease Diagnostics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on technology, animal type, infection type and end user.

Breakup by Technology:

Immunodiagnostics

Molecular Diagnostics

Others

Immunodiagnostics accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the technology. This includes immunodiagnostics, molecular diagnostics, and others. According to the report, immunodiagnostics represented the largest segment.

According to the veterinary infectious disease diagnostics market research report, the immunodiagnostics segment holds the largest market share due to the increasing demand for accurate disease detection. Immunodiagnostic tests, including enzyme-linked immunosorbent assays (ELISA) and immunofluorescence assays (IFA), are essential for their ability to specifically detect antibodies or antigens related to infectious diseases. This precision is critical in identifying pathogens and diagnosing diseases at early stages, which is crucial for effective treatment and disease management. As veterinary care becomes more sophisticated, there is a growing expectation for highly reliable diagnostic tools that can provide definitive results quickly. The escalating prevalence of infectious diseases in pets and livestock has heightened the need for such accurate diagnostic solutions.

Breakup by Animal Type:

Companion Animals

Food Producing Animals

Companion animals holds the largest share of the industry

A detailed breakup and analysis of the market based on the animal type have also been provided in the report. This includes companion animals and food producing animals. According to the report, companion animals accounted for the largest market share.

The companion animals segment in the veterinary infectious disease diagnostics market is driven by the focus on pet health and wellness, as well as advancements in diagnostic technology. Furthermore, the increasing prioritization of early disease detection by pet owners, who are more aware of the benefits of proactive health management are driving the market growth. This heightened awareness results in a growing demand for diagnostic services that can identify diseases before they become severe, leading to better health outcomes for pets. The segment is also driven by the availability of advanced diagnostic tools, such as molecular assays and rapid point-of-care tests, which offer accurate and timely results. These innovations enable veterinarians to diagnose and treat infections more effectively, enhancing the overall quality of care for companion animals.

Breakup by Infection Type:

Bacterial Infections

Viral Infections

Parasitic Infections

Others

Bacterial infections represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the infection type. This includes bacterial infections, viral infections, parasitic infections, and others. According to the report, bacterial infections represented the largest segment.

The bacterial infections segment in the veterinary infectious disease diagnostics market is driven by the burgeoning prevalence of bacterial diseases among animals, which necessitates advanced diagnostic tools for effective management and control. The rising incidence of bacterial infections such as leptospirosis, tuberculosis, and salmonella in both pets and livestock fuels demand for precise diagnostic solutions. The growing awareness of the impact of bacterial diseases on animal health and productivity also drives the need for robust diagnostic methods to ensure early detection and intervention. Additionally, the segment is driven by the shifting focus on food safety, as bacterial infections in livestock can lead to contamination of the food supply, prompting stringent testing and monitoring requirements. The expansion of veterinary healthcare infrastructure and services, particularly in emerging economies, supports the growth of this segment by enhancing access to diagnostic technologies.

Breakup by End User:

Reference Laboratories

Veterinary Laboratories and Clinics

Point of Care/In House Testing

Research Institutes and Universities

Reference laboratories dominates the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes reference laboratories, veterinary laboratories and clinics, point of care/in house testing, and research institutes and universities. According to the report, reference laboratories represented the largest segment.

The reference laboratories segment in the veterinary infectious disease diagnostics market is driven by the escalating complexity of diagnostic testing requirements. As veterinary diagnostics become more sophisticated, reference laboratories are increasingly relied upon for their advanced capabilities and specialized expertise. The segment is driven by the surging need for accurate and comprehensive diagnostic tests that can differentiate between various pathogens and diseases. This complexity necessitates the use of highly specialized equipment and skilled personnel, which are hallmarks of reference laboratories. Additionally, the segment benefits from the increasing volume of diagnostic samples that require thorough and high-resolution analysis, further underscoring the need for reference laboratories. The rising demand for advanced testing methods, such as molecular diagnostics and genomic analysis, drives the need for specialized reference laboratories capable of conducting these tests with high precision.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest veterinary infectious disease diagnostics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for veterinary infectious disease diagnostics.

The North American veterinary infectious disease diagnostics market is driven by the growing prevalence of infectious diseases among pets and livestock. The rising incidence of diseases such as canine distemper, feline leukemia, and various zoonotic infections in the region underscores the need for effective diagnostic solutions. The regional market is also driven by the burgeoning awareness among pet owners about the importance of early detection and prevention of diseases. Pet owners in North America are more informed and proactive about their pets' health, which fuels demand for advanced diagnostic services. Moreover, the surging technological advancements in veterinary diagnostics, including innovations in molecular biology, rapid testing methods, and automated analyzers, are supporting the market growth. These advancements enhance the accuracy, speed, and efficiency of diagnostic processes. Apart from this, the market is driven by the escalating focus on veterinary research and development (R&D), supported by substantial investments from both private and public sectors.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the veterinary infectious disease diagnostics industry include Abbott Laboratories, Biomerieux SA, Creative Diagnostics, HESKA Corporation, Innovative Diagnostics, IDEXX Laboratories Inc., Neogen Corporation, Qiagen N.V., Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Some of the key veterinary infectious disease diagnostics companies in the market are actively engaged in several strategic initiatives to maintain their competitive edge and drive market growth. These companies are focusing on extensive R&D to innovate and enhance diagnostic technologies. By investing heavily in R&D, they aim to introduce advanced diagnostic tools, such as molecular assays and rapid testing devices, that offer greater accuracy and speed in detecting infectious diseases. Collaboration with research institutions and academic organizations is also a priority, facilitating the development of cutting-edge technologies and solutions. Additionally, these players are expanding their product portfolios through strategic acquisitions and partnerships, enabling them to offer a broader range of diagnostic solutions and enter new markets. They are also enhancing their manufacturing capabilities to meet the growing demand for high-quality diagnostic products. Key players are also adopting digital technologies and data analytics to improve diagnostic processes and provide integrated solutions that offer real-time results and predictive insights.

Veterinary Infectious Disease Diagnostics Market News:

In 2023, IDEXX Laboratories introduced a pioneering veterinary diagnostic test to detect kidney injury in cats and dogs. This test, which is the first of its kind, is part of IDEXX's strategy to expand its portfolio with advanced diagnostic solutions that address unmet needs in veterinary care. The new test is expected to significantly improve early diagnosis and treatment outcomes for pets, enhancing their quality of life and extending lifespans.

In 2023, Mars acquired HESKA Corporation to integrate HESKA into Mars Petcare's Science & Diagnostics division, significantly broadening access to advanced diagnostic technologies and accelerating research and development initiatives. This acquisition is expected to enhance HESKA's capabilities in delivering comprehensive diagnostic solutions, including point-of-care diagnostics, telemedicine, and innovative technologies for veterinary professionals globally.

In 2024, Neogen Corporation expanded its product line with the introduction of the SureKill Gel Bait Pro Applicator. This new addition to the SureKill line aims to enhance pest control solutions, particularly in environments where animal health is a priority. The applicator is designed to provide efficient and effective pest control, ensuring safer and healthier conditions for livestock and pets.

Key Questions Answered in This Report:

• How has the global veterinary infectious disease diagnostics market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global veterinary infectious disease diagnostics market?
• What is the impact of each driver, restraint, and opportunity on the global veterinary infectious disease diagnostics market?
• What are the key regional markets?
• Which countries represent the most attractive veterinary infectious disease diagnostics market?
• What is the breakup of the market based on the technology?
• Which is the most attractive technology in the veterinary infectious disease diagnostics market?
• What is the breakup of the market based on the animal type?
• Which is the most attractive animal type in the veterinary infectious disease diagnostics market?
• What is the breakup of the market based on the infection type?
• Which is the most attractive infection type in the veterinary infectious disease diagnostics market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the veterinary infectious disease diagnostics market?
• What is the competitive structure of the market?
• Who are the key players/companies in the global veterinary infectious disease diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Veterinary Infectious Disease Diagnostics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Technology

• 6.1 Immunodiagnostics
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Molecular Diagnostics
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Animal Type

• 7.1 Companion Animals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Food Producing Animals
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Infection Type

• 8.1 Bacterial Infections
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Viral Infections
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Parasitic Infections
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by End User

• 9.1 Reference Laboratories
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Veterinary Laboratories and Clinics
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Point of Care/In House Testing
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Research Institutes and Universities
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Biomerieux SA
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Creative Diagnostics
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 HESKA Corporation
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Innovative Diagnostics
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 IDEXX Laboratories Inc.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Neogen Corporation
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Qiagen N.V.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Randox Laboratories Ltd
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Thermo Fisher Scientific Inc
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Virbac
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis